ICD-10-CM Billable Code

D3A.094

Benign carcinoid tumor of the foregut, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the foregut, classified under ICD-10 code D3A.094, is a non-cancerous growth that develops from neuroendocrine cells in the foregut, which includes parts of the esophagus, stomach, and the beginning of the small intestine. Despite being benign, these tumors require careful medical observation and management to prevent potential complications. They are generally slow-growing and may not cause noticeable symptoms in the early stages, making diagnosis an important step in treatment planning.

Causes & Symptoms

Clinical Causes: Genetic factors that may predispose individuals to develop neuroendocrine tumors Unknown environmental or lifestyle influences Possible associations with certain genetic syndromes, such as Multiple Endocrine Neoplasia (MEN)

Key Symptoms: Often asymptomatic and discovered incidentally during examinations for other conditions Abdominal pain or discomfort if the tumor grows and presses on surrounding organs Digestive disturbances such as nausea or vomiting Unexplained weight loss in some cases Rarely, hormonal symptoms like flushing or diarrhea if the tumor secretes active substances

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and specialized tests, including: - Imaging studies such as CT scans or MRI to identify the tumor’s location and size - Endoscopic examinations to visualize the gastrointestinal tract - Biopsy of the tumor tissue to ascertain benign nature and confirm neuroendocrine origin - Blood and urine tests to check for hormones or markers associated with neuroendocrine activity Proper diagnosis is essential to distinguish benign carcinoid tumors from malignant counterparts and plan appropriate management.

Treatment Protocols: Treatment strategies generally focus on removal and monitoring, including: - Surgical excision of the tumor to eliminate the growth and prevent progression - Minimally invasive procedures such as endoscopic resection in suitable cases - Regular follow-up with imaging and clinical assessments to detect any recurrence or changes - In cases where surgery is not feasible, careful observation and management of symptoms may be employed Multidisciplinary care involving surgeons, gastroenterologists, and oncologists is often necessary to determine the best approach.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.094 a billable ICD-10 code?
Yes, D3A.094 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.094?
Clinical documentation must specify the nature of Benign carcinoid tumor of the foregut, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference